Real-time PCR in clinical microbiology: verification, validation, and contamination control

Clinical Microbiology Newsletter

Volumn 29, Issue 12, 2007, Pages 87-95

  Sloan, Lynne M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; ARTICLE; CLINICAL PRACTICE; CROSS REACTION; HUMAN; LABORATORY TEST; MICROBIAL CONTAMINATION; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PRACTICE GUIDELINE; PROFESSIONAL COMPETENCE; QUALITY CONTROL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION PROCESS;

EID: 34249937313     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinmicnews.2007.05.002     Document Type: Article

References (28)

1. Mackay I.M. Real-time PCR in the microbiology laboratory. Clin. Microbiol. Infect. 10 (2004) 190-212
2. Clinical and Laboratory Standards Institute. 2006. Molecular diagnostic methods for Infectious diseases: approved guideline. CLSI document MM3-A2. CLSI, Wayne, PA.
3. Rodrigues, G. 2003. Improving Method Validation Results by Optimizing Pipette Calibration Frequency, p. 1-2. In Abstracts of the 7th Annual WCBP Symposium, San Francisco, CA.
4. U.S. Department of Health and Human Services, Centers for Medicare and Medicaid. CLIA brochures. Verification of performance specifications brochure 2: What is it and how do I do it? (2003). http://www.cms.hhs.gov/CLIA/downloads/6064bk.pdf
5. Elder B.L., et al. Verification and validation of procedures in the clinical microbiology laboratory. Cumitech 31 (1997) 1-18
6. Clinical and Laboratory Standards Institute. 2002. User protocol for evaluation of qualitative test performance: approved guideline. CLSI document EP12-A. CLSI, Wayne, PA.
7. Clinical and Laboratory Standards Institute. 2005. User verification of performance for precision and trueness: approved guideline. CLSI document EP15-A2. CLSI, Wayne, PA.
8. U.S. Department of Health and Human Services, Centers for Medicare and Medicaid. Medicare, Medicaid, and CLIA programs; laboratory requirements relating to quality systems and certain personnel qualifications; final rule. 42 CFR Part 493. Federal Register 68 (2003) 3640-3714
9. Clinical and Laboratory Standards Institute. 2000. How to define and determine reference intervals in the clinical laboratory: approved guideline. CLSI document C28-A2. CLSI, Wayne, PA.
10. Clinical and Laboratory Standards Institute. 2002. Method comparison and bias estimation using patient samples: approved guideline. CLSI document EP09-A2. CLSI, Wayne, PA.
11. Barry P.L., et al. Method validation - reference interval transference. In: Westgard J.O. (Ed). Basic method validation. 2nd ed. (2003), Westgard Quality Corp, Madison, WI 163-172
12. Huber L. Method validation (2006). http://www.labcompliance.com/methods/meth_val.htm
13. Clinical and Laboratory Standards Institute. 2003. Quantitative molecular methods for infectious diseases: approved guidelines. CLSI document MM6-A. CLSI, Wayne, PA.
14. Westgard J.O. Final CLIA rule. Part V: method validation process and procedures (2003). http://westgard.com/cliafinalrule5.htm
15. Saah A., and Hoover D.R. "Sensitivity" and "specificity" reconsidered: the meaning of these terms in analytical and diagnostic settings. Ann. Intern. Med. 126 (1997) 91-94
16. Australian Pesticides and Veterinary Authority. Guidelines for the validation of analytical methods for active constituent, agricultural, and veterinary chemical products (2004). http://www.apvma.gov.au/guidelines/analytical_methods.pdf
17. Marsik F.J. Verification, validation of microbiology methods. Advance Newsmagazines (2000). http://laboratory-manager.advanceweb.com/common/EditorialSearch/AViewer. aspx?AN=AL_p32.html&AD=05-01-2000
18. Yost J.P.M. CLIA and equivalent quality control: options for the future. Lab. Med. 36 (2005) 614-616
19. Garrett P.E. Quality control for nucleic acid tests: common ground and special issues. J. Clin. Virol. 20 (2001) 15-21
20. Clinical and Laboratory Standards Institute. 2004. A quality system model for healthcare: approved guidelines. CLSI document HS1-A2. CLSI, Wayne, PA.
21. Sharp S., et al. Why perform training verification and competency assessment in clinical microbiology? American Society for Microbiology (2005). http://www.asm.org/Division/c/competency.htm
22. Sharp S.E., and Elder B.L. Competency assessment in the clinical microbiology laboratory. Clin. Microbiol. Rev. 17 (2004) 681-694
23. Wood N. Reducing the risk of contamination in PCR. W.A. Brown Industrial Sales (2002). http://www.lawmanlab.com/pcrcontamination.htm
24. Niesters H. Clinical virology in real time. J. Clin. Virol. 25 (2002) S3-S12
25. Espy M.J., et al. Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin. Microbiol. Rev. 19 (2006) 165-256
26. Smetsers T.F., et al. Freezing of PCR master mixture retains full amplification activity and facilitates PCR standardisation for molecular diagnostics and real-time quantitative PCR. Leukemia 12 (1998) 1324-1325
27. Wright, P. A. et al. 2005. Presented at the Clinical Virology Symposium, Clearwater Beach, FL, May 8-11.
28. Borst A., Box A.T., and Fluit A.C. False-positive results and contamination in nucleic acid amplification assays: suggestions for a prevent and destroy strategy. Eur. J. Clin. Microbiol. Infect. Dis. 23 (2004) 289-299